Latest 麻豆女优 Health News Stories
Shopping Abroad For Cheaper Medication? Here鈥檚 What You Need To Know
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here鈥檚 some advice.
驴Buscas medicamentos m谩s baratos en el exterior? Esto es lo que debes saber
Los estadounidenses eluden la ley federal cruzando a Canad谩 y M茅xico, o recurriendo a farmacias en l铆nea en el extranjero para comprar medicamentos recetados a una fracci贸n del precio que pagar铆an en casa.
Tecnolog铆a casera ofrece m谩s libertad a los pacientes para controlar su diabetes
La diabetes tipo 1 es una condici贸n cr贸nica que requiere un estricto control de la glucosa y la administraci贸n de la cantidad de insulina precisa. Pacientes crearon un sistema para mantener ese equilibrio vital.
DIY Tech Gives People More Freedom In Managing Diabetes
People with diabetes say they鈥檝e been waiting for years for better technology to manage their chronic condition. Tired of waiting, some tech-savvy, do-it-yourselfers are constructing their own devices using open-source programming instructions.
KHN filed multiple Freedom of Information Act requests over months, and the FDA responded Wednesday saying the data about device malfunctions is now publicly available online.
Five Things We Found In The FDA鈥檚 Hidden Device Database
The Food and Drug Administration released two decades of previously hidden data containing millions of injuries or malfunctions by medical devices. Here鈥檚 what we鈥檝e learned so far.
FDA Overlooked Red Flags In Drugmaker鈥檚 Testing of New Depression Medicine
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
More Than Half Of Surgical Stapler Malfunctions Went To Hidden FDA Database
The FDA reveals that 56,000 malfunctions associated with surgical staplers weren鈥檛 reported through its traditional public reporting system.
Hidden Reports Masked The Scope Of Widespread Harm From Faulty Heart Device
The Food and Drug Administration allowed one company to send 50,000 reports of harm or malfunctions to an internal database even as patients worried about faulty defibrillators lodged in their hearts.
Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads 鈥 just like side effects.
FDA To End Program That Hid Millions Of Reports On Faulty Medical Devices
In the wake of a KHN investigation, the agency will no longer let device makers file reports of harm outside a widely used public database.
Prestigiosos hospitales se lanzan al negocio de terapias con c茅lulas madre no aprobadas
Los tratamientos t铆picos consisten en inyectar las articulaciones de los pacientes con sus propias c茅lulas grasas o de m茅dula 贸sea, o con extractos de plaquetas. No est谩 comprobado cient铆ficamente que funcionen.
Elite Hospitals Plunge Into Unproven Stem Cell Treatments
Critics are concerned about the explosion in controversial stem cell procedures offered by clinics 鈥 and, increasingly, respected hospitals.
Health Officials鈥 Plug For Next FDA Chief: Go Big On E-Cig Regulation
With Scott Gottlieb making his exit from the Food and Drug Administration鈥檚 top spot, city and country health officials call for backup in the fight to curb teen use of e-cigarettes.
FDA Chief Calls For Release Of All Data Tracking Problems With Medical Devices
In the wake of a KHN investigation, Scott Gottlieb says releasing the records is in the public interest.
Device-Safety Experts To FDA: Make Data Public
For almost two decades, device makers have sent reports of incidents to databases hidden from public view.
Analysis: Why Americans Shouldn鈥檛 Feel Grateful For $137 Insulin
Only by the bizarre logic of the U.S. pharmaceutical industry does this drug count as any kind of generic.
FDA Chief Calls For Stricter Scrutiny Of Electronic Health Records
In an interview, FDA Commissioner Scott Gottlieb reacts to a KHN/Fortune investigation of the drawbacks and risks of electronic health records.
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Surprise! Fixing Surprise Medical Bills Is Harder Than it Looks
Joanne Kenen of Politico, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss the efforts to curb 鈥渟urprise鈥 medical bills to patients who inadvertently get out-of-network care; a look at where the 2020 presidential candidates stand on health; and the Trump administration鈥檚 efforts to end HIV in the U.S. Also, Rovner interviews Food and Drug Administration Commissioner Scott Gottlieb, who is leaving his job in early April.
